[1]
Chantharakhit, C. 2019. Efficacy of dose modification of gefitinib after hepatotoxicity in late-line treatment of EGFR mutated advanced non-small cell lung cancer: A case report. Biomedical Sciences and Clinical Medicine. 58, 2 (Apr. 2019), 99–104.